• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/69

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

69 Cards in this Set

  • Front
  • Back
Acetylcholine
Agonist of muscarinic and nicotinic receptors
Methacholine
Agonist of muscarinic receptors
Carbachol
Agonist of muscarinic receptors (some nicotinic effect)
Bethanechol
Agonist of muscarinic receptors
Pilocarpine
Muscarinic agonist
Muscarine
Muscarinic agonist
Nicotine
Initially activates ganglionic nACh receptors
Edrophonium
Simple competitive inhibitor of AChE
Physostigmine
Competitive substrate of AChE
Neostigmine
Competitive substrate of AChE
Pyridostigmine
Competitive substrate of AChE
Echothiophate
Inactivate active AChE site by covalent attachment (bind to serine site)
Malathion
Inactivate active AChE site by covalent attachment (bind to serine site)
Parathion
Inactivate active AChE site by covalent attachment (bind to serine site)
Sarin/Soman
Inactivate active AChE site by covalent attachment (bind to serine site)
Atropine
Muscarinic antagonist
Scopolamine
Muscarinc antagonist
Tropicamide, Cyclopentolate, Homotropine
Muscarinic antagonist
Ipratropium, tiotropium
Muscarinic antagonist
Tolterodine
Muscarinic antagonist (Bladder)
Dicyclomine
Muscarinic antagonist (GI)
Glycopyrrolate
Muscarinic antagonist
Benzotropine
Muscarinic antagonist
Hexamethonium (C6)
Ganglionic Nicotinic antagonist
Mecamylamine
Ganglionic Nicotinic antagonist
Norepinephrine
Alpha agonist (does not activate beta-2)
Dopamine
Renal Vasodilation (D1), Inhibition of NE Release (D2), Cardiac Stimulation (beta-1), Increased BP (alpha)
Epinephrine
Beta-agonist (low), alpha and beta (moderate), alpha agonist (high)
Isoproterenol
beta-agonist
Dobutamine
beta-agonist (primarily beta-1)
Albuterol, metaproterenol
beta-2 agonist
Terbutaline, ritodrine
beta-2 agonist
Salmeterol
beta-2 agonist
Phenylephrine
alpha-1 agonist
Methoxamine
alpha-1 agonist
Clonidine
alpha-2 agonist
Methyldopa
alpha-2 agonist
Ephedrine, Pseudoephedrine
NE agonist (periphery and CNS)
Amphetamine
Reverses NE transporter
Cocaine
Blocks NE reuptake, blocks DA reuptake (CNS)
Tyramine
NE agonist (release)
Phenoxybenzamine
Non-selective, irreversible alpha blocker
Phentolamine
non-selective alpha blocker
Prazosin
selective alpha-1 blocker
Doxazosin, terazosin
selective alpha-1 blocker
Tamsulosin
selective alpha-1A/D blocker
Yohimbine
selective alpha-2 blocker
Propranolol
non-selective beta blocker
Timolol
non-selective beta blocker
Nadolol
non-selective beta blocker
Atenolol, metoprolol
beta-1 blocker
Esmolol
beta-1 blocker
Betaxolol
beta-1 blocker
Labetalol
beta blocker, alpha-1 blocker
Carvedilol
beta blocker, alpha blocker
Pindolol
non-selective beta blocker
Acebutolol
beta-1 blocker
Aliskiren
inhibits renin
Captopril (Class I)
inhibit ACE, reduce breakdown of bradykinin
Enalopril (Class II)
inhibit ACE, reduce breakdown of bradykinin
Lisinopril (Class III)
inhibit ACE, reduce breakdown of bradykinin
Losartan
AT1 receptor antagonist
Valsartan
AT1 receptor antagonist
Spironolactone, eplerenone
aldosterone antagonist in cortical collecting tubule and late distal tubule
HCTZ
inhibit NaCl absorption in DCT
Furosemide, bumetanide
inhibit NKCC2 in ascending loop
amiloride, triamterence
inhibit ENaC channel in CD
Conivaptan
inhibit V1 and V2 receptors (decrease AQ2 synthesis)
Tolvaptan
oral V2 antagonist